Major talcum powder verdicts are reshaping corporate liability, public health debates, and mass tort litigation nationwide.
Opinion: Judges must enforce the rigorous scrutiny that Federal Rule of Evidence 702 requires, particularly when scientific evidence is mixed or fragile.
Lawyers nationwide are gearing up for bellwether ovarian cancer trials against Johnson & Johnson this year, but a plaintiff ...
Across Talc, Depo-Provera, and Cartiva litigation, Legal Bay continues to provide pre-settlement funding, post-verdict funding, and, where applicable, appellate funding solutions. Mass tort and ...
Add Yahoo as a preferred source to see more of our stories on Google. Pharmaceutical giant Johnson & Johnson is facing a major lawsuit over claims that it knowingly sold baby powder contaminated with ...
Johnson & Johnson (NYSE:JNJ) was found liable by a Philadelphia jury in an ovarian cancer case linked to long term use of its talc based baby powder. The jury awarded compensatory and punitive damages ...
U.S. Magistrate Judge Rukhsanah Singh, in the District of New Jersey, rejected Beasley Allen's request to hold off her decision on whether to disqualify the plaintiffs' firm from leadership of the ...
More than 1,300 Victorians have joined a class action against Johnson & Johnson alleging its talcum powder products left them with ovarian cancer, mesothelioma (cancer affecting the lungs), and other ...
A jury has ordered Johnson & Johnson to pay $966 million to the family of a woman who died from mesothelioma, according to reports. The verdict in a Los Angeles court is one of the largest against J&J ...
TORONTO, March 6, 2026 /CNW/ - A Canada-wide talc class action was certified against Johnson & Johnson on March 4, 2026, by Justice Leiper of the Ontario Superior Court of Justice. This class action ...
The International Agency for Research on Cancer classified talc as “probably carcinogenic to humans” based on limited human evidence, sufficient animal evidence, and strong mechanistic data, drawing a ...
Johnson & Johnson is willing to pay almost $9 billion to settle thousands of lawsuits alleging that its talcum powder caused cancers, the company announced Apr. 4. The proposal is the latest chapter ...